Top

Archives of Gynecology and Obstetrics

Published in:

01-09-2012 | Maternal-Fetal Medicine

Blood loss after caesarean section: depending on the management of oxytocin application?

Authors: Telja Pursche, Klaus Diedrich, Constanze Banz-Jansen

Published in: Archives of Gynecology and Obstetrics | Issue 3/2012

Abstract

Purpose

Oxytocin donation in caesarean section is used to reduce postpartum blood loss. Cardiovascular side effects such as tachycardia, hypotension and decreased cardiac output are known and seem to depend on the way of application, whereas the blood loss is said to be similar. We aimed to examine that extent of haemorrhage in our own patients.

Method

In July 2011, the perioperative oxytocin management was changed and the postpartum was oxytocin bolus abolished. Retrospectively, we reviewed the pre- and postpartum haemoglobin in all women who had undergone caesarean section in the year 2011 at the University Hospital of Schleswig-Holstein, Campus Luebeck.

Results

We found a significantly higher blood loss in those patients who were treated without oxytocin bolus but only with oxytocin infusion (−10.5 vs. −9 g/dl).

Conclusion

We recommend to do further studies to clarify the advantage and contraindications of using oxytocin boluses and until to use the oxytocin bolus again in healthy patients but to avoid it in patients with cardiovascular risk.

King KJ, Douglas MJ, Unger W, Wong A, King RA (2010) Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial. Anesth Analg 111(6):1460–1466PubMedCrossRef

Murphy DJ, MacGregor H, Munishankar B, McLeod G (2009) A randomised controlled trial of oxytocin 5 IU and placebo infusion versus oxytocin 5 IU and 30 IU infusion for the control of blood loss at elective caesarean section–pilot study. Eur J Obstet Gynecol Reprod Biol 142(1):30–33PubMedCrossRef

Sheehan SR, Montgomery AA, Carey M, McAuliffe FM, Eogan M, Gleeson R, Geary M, Murphy DJ, ECSSIT Study Group (2011) Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ 1(343):d4661CrossRef

Hendricks CH, Brenner WE (1970) Cardiovascular effects of oxytocin drugs used post partum. Am J Obstet Gynecol 108:751–760PubMed

Palmer CM, Norris MC, Giudici MC et al (1990) Incidence of electrocardiographic changes during caesarean delivery under regional anesthesia. Anesth Analg 70:36–43PubMedCrossRef

Svanström MC, Biber B, Hanes M, Johansson G, Näslund U, Balfors EM (2008) Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth 100:683–689PubMedCrossRef

Jonsson M, Hanson U, Lidell C, Nordén-Lindeberg S (2010) ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG 117(1):76–83PubMedCrossRef

Mathew JP, Fleisher LA, Rinehouse JA et al (1992) ST segment depression during labour and delivery. Anesthesiology 77:635–641PubMedCrossRef

McLintic AJ, Pringle SD, Lilley S et al (1992) Electrocardiographic changes during caesarean section under regional anesthesia. Anesth Analg 74:51–56PubMedCrossRef

10.

Pinder AJ, Dresner M, Calow C, O’Riordan J, Johnson R (2002) Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth 11:156–159PubMedCrossRef

11.

Weis FR Jr, Markello R, Mo B, Bochiechio P (1975) Cardiovascular effects of oxytocin. Obstet Gynecol 46:211–214PubMed

12.

Thomas JS, Koh SH, Cooper GM (2007) Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. BJA 98(1):116–119PubMedCrossRef

13.

Thomas TA, Cooper GM, Editorial Board of the Confidential Enquiries into Maternal Deaths in the United Kingdom (2002) Maternal deaths from anaesthesia. An extract from why mothers die 1997–1999, the confidential enquiries into maternal deaths in the United Kingdom. Br J Anaesth 89(3):499–508PubMed

14.

National Collaborating Centre for Women’s and Children’s Health (1900) Caesarean section clinical guideline 2004. Royal College of Obstetricians and Gynaecologists’ Press, London, vol 12, p 11

15.

Schuurmans N, MacKinnon C, Lane C, Etches D (2000) Society of Obstetricians and Gynaecologists of Canada clinical practice guidelines: prevention and management of postpartum haemorrhage. J SOCG 88:1–11

Title: Blood loss after caesarean section: depending on the management of oxytocin application?
Authors: Telja Pursche
Klaus Diedrich
Constanze Banz-Jansen
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 3/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2334-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Blood loss after caesarean section: depending on the management of oxytocin application?

Abstract

Purpose

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2012

Efficacy of cryoanalgesia in decreasing pain during second trimester genetic amniocentesis: a randomized trial

Intraabdominal adhesion formation is associated with differential mRNA expression of metabolic genes PDHb and SDHa

Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trial

Clinical significance of amphiregulin and epidermal growth factor in colostrum

Isolated contralateral groin relapse in vulvar cancer

Visual pain mapping in endometriosis